Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 30
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Neuroendocrinology ; 113(2): 107-119, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-34915491

RESUMEN

Identification of the molecular mechanisms governing neuroendocrine secretion and resulting intercellular communication is one of the great challenges of cell biology to better understand organism physiology and neurosecretion disruption-related pathologies such as hypertension, neurodegenerative, or metabolic diseases. To visualize molecule distribution and dynamics at the nanoscale, many imaging approaches have been developed and are still emerging. In this review, we provide an overview of the pioneering studies using transmission electron microscopy, atomic force microscopy, total internal reflection microscopy, and super-resolution microscopy in neuroendocrine cells to visualize molecular mechanisms driving neurosecretion processes, including exocytosis and associated fusion pores, endocytosis and associated recycling vesicles, and protein-protein or protein-lipid interactions. Furthermore, the potential and the challenges of these different advanced imaging approaches for application in the study of neuroendocrine cell biology are discussed, aiming to guide researchers to select the best approach for their specific purpose around the crucial but not yet fully understood neurosecretion process.


Asunto(s)
Secreciones Corporales , Exocitosis , Exocitosis/fisiología , Diagnóstico por Imagen
2.
FASEB J ; 34(5): 6769-6790, 2020 05.
Artículo en Inglés | MEDLINE | ID: mdl-32227388

RESUMEN

Chromogranin A (CgA) is a key luminal actor of secretory granule biogenesis at the trans-Golgi network (TGN) level but the molecular mechanisms involved remain obscure. Here, we investigated the possibility that CgA acts synergistically with specific membrane lipids to trigger secretory granule formation. We show that CgA preferentially interacts with the anionic glycerophospholipid phosphatidic acid (PA). In accordance, bioinformatic analysis predicted a PA-binding domain (PABD) in CgA sequence that effectively bound PA (36:1) or PA (40:6) in membrane models. We identified PA (36:1) and PA (40:6) as predominant species in Golgi and granule membranes of secretory cells, and we found that CgA interaction with these PA species promotes artificial membrane deformation and remodeling. Furthermore, we demonstrated that disruption of either CgA PABD or phospholipase D (PLD) activity significantly alters secretory granule formation in secretory cells. Our findings show for the first time the ability of CgA to interact with PLD-generated PA, which allows membrane remodeling and curvature, key processes necessary to initiate secretory granule budding.


Asunto(s)
Cromogranina A/metabolismo , Aparato de Golgi/metabolismo , Ácidos Fosfatidicos/metabolismo , Fosfolipasa D/fisiología , Vesículas Secretoras/fisiología , Animales , Células COS , Chlorocebus aethiops , Ratones , Ratones Noqueados
3.
IUBMB Life ; 72(4): 524-532, 2020 04.
Artículo en Inglés | MEDLINE | ID: mdl-31891241

RESUMEN

Chromogranin A (CgA) is a soluble glycoprotein stored with hormones and neuropeptides in secretory granules (SG) of most (neuro)endocrine cells and neurons. Since its discovery in 1967, many studies have reported its structural characteristics, biological roles, and mechanisms of action. Indeed, CgA is both a precursor of various biologically active peptides and a granulogenic protein regulating the storage and secretion of hormones and neuropeptides. This review emphasizes the findings and theoretical concepts around the CgA-linked molecular machinery controlling hormone/neuropeptide aggregation and the interaction of CgA-hormone/neuropeptide aggregates with the trans-Golgi membrane to allow hormone/neuropeptide targeting and SG biogenesis. We will also discuss the intriguing alteration of CgA expression and secretion in various neurological disorders, which could provide insights to elucidate the molecular mechanisms underlying these pathophysiological conditions.


Asunto(s)
Cromogranina A/fisiología , Enfermedades del Sistema Nervioso/metabolismo , Sistemas Neurosecretores/metabolismo , Animales , Calcio/metabolismo , Hormonas/metabolismo , Humanos , Vesículas Secretoras/metabolismo
4.
Exp Dermatol ; 28(8): 922-932, 2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-30659649

RESUMEN

It is well recognized that the world population is ageing rapidly. Therefore, it is important to understand ageing processes at the cellular and molecular levels to predict the onset of age-related diseases and prevent them. Recent research has focused on the identification of ageing biomarkers, including those associated with the properties of the Golgi apparatus. In this context, Golgi-mediated glycosylation of proteins has been well characterized. Additionally, other studies show that the secretion of many compounds, including pro-inflammatory cytokines and extracellular matrix-degrading enzymes, is modified during ageing, resulting in physical and functional skin degradation. Since the Golgi apparatus is a central organelle of the secretory pathway, we investigated its structural organization in senescent primary human dermal fibroblasts using confocal and electron microscopy. In addition, we monitored the expression of Golgi-related genes in the same cells. Our data showed a marked alteration in the Golgi morphology during replicative senescence. In contrast to its small and compact structure in non-senescent cells, the Golgi apparatus exhibited a large and expanded morphology in senescent fibroblasts. Our data also demonstrated that the expression of many genes related to Golgi structural integrity and function was significantly modified in senescent cells, suggesting a relationship between Golgi apparatus function and ageing.


Asunto(s)
Senescencia Celular , Fibroblastos/metabolismo , Aparato de Golgi/ultraestructura , Adulto , Aparato de Golgi/metabolismo , Humanos , Cultivo Primario de Células
5.
J Neurochem ; 137(6): 904-12, 2016 06.
Artículo en Inglés | MEDLINE | ID: mdl-26877188

RESUMEN

The regulated secretory pathway begins with the formation of secretory granules by budding from the Golgi apparatus and ends by their fusion with the plasma membrane leading to the release of their content into the extracellular space, generally following a rise in cytosolic calcium. Generation of these membrane-bound transport carriers can be classified into three steps: (i) cargo sorting that segregates the cargo from resident proteins of the Golgi apparatus, (ii) membrane budding that encloses the cargo and depends on the creation of appropriate membrane curvature, and (iii) membrane fission events allowing the nascent carrier to separate from the donor membrane. These secretory vesicles then mature as they are actively transported along microtubules toward the cortical actin network at the cell periphery. The final stage known as regulated exocytosis involves the docking and the priming of the mature granules, necessary for merging of vesicular and plasma membranes, and the subsequent partial or total release of the secretory vesicle content. Here, we review the latest evidence detailing the functional roles played by lipids during secretory granule biogenesis, recruitment, and exocytosis steps. In this review, we highlight evidence supporting the notion that lipids play important functions in secretory vesicle biogenesis, maturation, recruitment, and membrane fusion steps. These effects include regulating various protein distribution and activity, but also directly modulating membrane topology. The challenges ahead to understand the pleiotropic functions of lipids in a secretory granule's journey are also discussed. This article is part of a mini review series on Chromaffin cells (ISCCB Meeting, 2015).


Asunto(s)
Gránulos Citoplasmáticos/fisiología , Lípidos/fisiología , Fusión de Membrana/fisiología , Vesículas Secretoras/fisiología , Animales , Transporte Biológico/fisiología , Calcio/metabolismo , Exocitosis/fisiología , Humanos
6.
Biochem J ; 443(2): 387-96, 2012 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-22250954

RESUMEN

Golgi-associated long coiled-coil proteins, often referred to as golgins, are involved in the maintenance of the structural organization of the Golgi apparatus and the regulation of membrane traffic events occurring in this organelle. Little information is available on the contribution of golgins to Golgi function in cells specialized in secretion such as endocrine cells or neurons. In the present study, we characterize the intracellular distribution as well as the biochemical and functional properties of a novel long coiled-coil protein present in neuroendocrine tissues, NECC1 (neuroendocrine long coiled-coil protein 1). The present study shows that NECC1 is a peripheral membrane protein displaying high stability to detergent extraction, which distributes across the Golgi apparatus in neuroendocrine cells. In addition, NECC1 partially localizes to post-Golgi carriers containing secretory cargo in PC12 cells. Overexpression of NECC1 resulted in the formation of juxtanuclear aggregates together with a slight fragmentation of the Golgi and a decrease in K+-stimulated hormone release. In contrast, NECC1 silencing did not alter Golgi architecture, but enhanced K+-stimulated hormone secretion in PC12 cells. In all, the results of the present study identify NECC1 as a novel component of the Golgi matrix and support a role for this protein as a negative modulator of the regulated trafficking of secretory cargo in neuroendocrine cells.


Asunto(s)
Aparato de Golgi/metabolismo , Proteínas de Homeodominio/metabolismo , Proteínas de la Membrana/metabolismo , Animales , Transporte Biológico , Silenciador del Gen , Proteínas de Homeodominio/genética , Proteínas de la Membrana/genética , Células Neuroendocrinas/metabolismo , Células PC12 , Ratas
7.
J Biol Chem ; 285(13): 10030-10043, 2010 Mar 26.
Artículo en Inglés | MEDLINE | ID: mdl-20061385

RESUMEN

Processes underlying the formation of dense core secretory granules (DCGs) of neuroendocrine cells are poorly understood. Here, we present evidence that DCG biogenesis is dependent on the secretory protein secretogranin (Sg) II, a member of the granin family of pro-hormone cargo of DCGs in neuroendocrine cells. Depletion of SgII expression in PC12 cells leads to a decrease in both the number and size of DCGs and impairs DCG trafficking of other regulated hormones. Expression of SgII fusion proteins in a secretory-deficient PC12 variant rescues a regulated secretory pathway. SgII-containing dense core vesicles share morphological and physical properties with bona fide DCGs, are competent for regulated exocytosis, and maintain an acidic luminal pH through the V-type H(+)-translocating ATPase. The granulogenic activity of SgII requires a pH gradient along this secretory pathway. We conclude that SgII is a critical factor for the regulation of DCG biogenesis in neuroendocrine cells, mediating the formation of functional DCGs via its pH-dependent aggregation at the trans-Golgi network.


Asunto(s)
Catecolaminas/metabolismo , Secretogranina II/metabolismo , Vesículas Secretoras/metabolismo , Animales , Células COS , Chlorocebus aethiops , Gránulos Cromafines/metabolismo , Silenciador del Gen , Vectores Genéticos , Concentración de Iones de Hidrógeno , Células Neuroendocrinas/metabolismo , Células PC12 , ARN Interferente Pequeño/metabolismo , Ratas , Proteínas Recombinantes de Fusión/metabolismo
8.
Adv Biol Regul ; 79: 100772, 2021 01.
Artículo en Inglés | MEDLINE | ID: mdl-33288473

RESUMEN

Lipids have emerged as important actors in an ever-growing number of key functions in cell biology over the last few years. Among them, glycerophospholipids are major constituents of cellular membranes. Because of their amphiphilic nature, phospholipids form lipid bilayers that are particularly useful to isolate cellular content from the extracellular medium, but also to define intracellular compartments. Interestingly, phospholipids come in different flavors based on their fatty acyl chain composition. Indeed, lipidomic analyses have revealed the presence in cellular membranes of up to 50 different species of an individual class of phospholipid, opening the possibility of multiple functions for a single class of phospholipid. In this review we will focus on phosphatidic acid (PA), the simplest phospholipid, that plays both structural and signaling functions. Among the numerous roles that have been attributed to PA, a key regulatory role in secretion has been proposed in different cell models. We review here the evidences that support the idea that mono- and poly-unsaturated PA control distinct steps in hormone secretion from neuroendocrine cells.


Asunto(s)
Exocitosis , Células Neuroendocrinas/metabolismo , Ácidos Fosfatidicos/química , Ácidos Fosfatidicos/metabolismo , Animales , Transporte Biológico , Membrana Celular/metabolismo , Humanos , Transducción de Señal
9.
Cell Mol Neurobiol ; 30(8): 1189-95, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21046450

RESUMEN

Chromogranin A (CgA) is a soluble glycoprotein stored along with hormones and neuropeptides in secretory granules of endocrine cells. In the last four decades, intense efforts have been concentrated to characterize the structure and the biological function of CgA. Besides, CgA has been widely used as a diagnostic marker for tumors of endocrine origin, essential hypertension, various inflammatory diseases, and neurodegenerative disorders such as amyotrophic lateral sclerosis and Alzheimer's disease. CgA displays peculiar structural features, including numerous multibasic cleavage sites for prohormone convertases as well as a high proportion of acidic residues. Thus, it has been proposed that CgA represents a precursor of biologically active peptides, and a "granulogenic protein" that plays an important role as a chaperone for catecholamine storage in adrenal chromaffin cells. The widespread distribution of CgA throughout the neuroendocrine system prompted several groups to investigate the role of CgA in peptide hormone sorting to the regulated secretory pathway. This review summarizes the findings and theoretical concepts around the molecular machinery used by CgA to exert this putative intracellular function. Since CgA terminal regions exhibited strong sequence conservation through evolution, our work focused on the implication of these domains as potential functional determinants of CgA. Characterization of the molecular signals implicating CgA in the intracellular traffic of hormones represents a major biological issue that may contribute to unraveling the mechanisms defining the secretory competence of neuroendocrine cells.


Asunto(s)
Cromogranina A/metabolismo , Hormonas Peptídicas/metabolismo , Vesículas Secretoras/metabolismo , Animales , Humanos , Modelos Biológicos , Hormonas Peptídicas/química , Estructura Cuaternaria de Proteína , Transporte de Proteínas
10.
J Neurosci Methods ; 335: 108596, 2020 04 01.
Artículo en Inglés | MEDLINE | ID: mdl-32035089

RESUMEN

BACKGROUND: Tyrosine hydroxylase (TH) catalyzes the rate-limiting step for the biosynthesis of the catecholamines dopamine, noradrenaline and adrenaline. Although its distribution in different organs, species and stages of development has been the subject of numerous studies, the recent emergence of 3D imaging techniques has created the potential to shed new light on the dynamics of TH expression during the development of the mammalian central and peripheral nervous systems. NEW METHOD: Here, we describe a flowchart summarizing different protocols adapted to developmental stage-specific tissues to generate a 3D atlas of the catecholaminergic system in the brain and peripheral nervous system in mice from embryonic to pre-weaning stages. The procedures described allowed a quantitative assessment of developing TH-positive neuronal populations and pathways, previously understudied due to dimensional limitations. RESULTS: Our approach allowed us to reveal in 3D the dynamics of the onset and the establishment of the catecholaminergic system in embryonic and developing central and peripheral nervous system. Quantitative analyses applied to 3D images yielded accurate measurements of neuron population volumes and numbers, and tract pathway dimensions for selected TH-positive brain structures. COMPARISON WITH EXISTING METHODS: We applied a set of different protocols to yield a comprehensive flowchart for 3D imaging and a precise quantitative assessment of specific neuronal populations during the course of their development up to adulthood in mice. CONCLUSION: The procedures described and the extensive 3D mapping of TH immunoreactivity at early embryonic and postnatal stages provide a comprehensive view of the onset and development of the catecholaminergic system in the mouse brain and sympathoadrenal nervous system.


Asunto(s)
Encéfalo , Tirosina 3-Monooxigenasa , Animales , Encéfalo/diagnóstico por imagen , Encéfalo/metabolismo , Catecolaminas , Femenino , Ratones , Embarazo , Diseño de Software , Tirosina 3-Monooxigenasa/metabolismo , Destete
11.
Cell Rep ; 32(7): 108026, 2020 08 18.
Artículo en Inglés | MEDLINE | ID: mdl-32814056

RESUMEN

Specific forms of fatty acids are well known to have beneficial health effects, but their precise mechanism of action remains elusive. Phosphatidic acid (PA) produced by phospholipase D1 (PLD1) regulates the sequential stages underlying secretory granule exocytosis in neuroendocrine chromaffin cells, as revealed by pharmacological approaches and genetic mouse models. Lipidomic analysis shows that secretory granule and plasma membranes display distinct and specific composition in PA. Secretagogue-evoked stimulation triggers the selective production of several PA species at the plasma membrane near the sites of active exocytosis. Rescue experiments in cells depleted of PLD1 activity reveal that mono-unsaturated PA restores the number of exocytotic events, possibly by contributing to granule docking, whereas poly-unsaturated PA regulates fusion pore stability and expansion. Altogether, this work provides insight into the roles that subspecies of the same phospholipid may play based on their fatty acyl chain composition.


Asunto(s)
Exocitosis/genética , Células Neuroendocrinas/metabolismo , Ácidos Fosfatidicos/metabolismo , Animales , Humanos , Ratones
12.
FASEB J ; 22(6): 1756-68, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18198219

RESUMEN

Selenoproteins contain the essential trace element selenium, the deficiency of which is associated with cancer or accelerated aging. Although selenoproteins are thought to be instrumental for the effects of selenium, the biological function of many of these proteins remains unknown. Here, we studied the role of selenoprotein T (SelT), a selenocysteine (Sec) -containing protein with no known function, which we have identified as a novel target gene of the neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) during PC12 cell differentiation. SelT was found to be ubiquitously expressed throughout embryonic development and in adulthood in rat. Immunocytochemical analysis revealed that SelT is mainly localized to the endoplasmic reticulum through a hydrophobic domain. PACAP and cAMP induced a rapid and long-lasting increase in SelT gene expression in PC12 cells, in a Ca(2+)-dependent manner. These results suggested a possible role of SelT in PACAP signaling during PC12 cell differentiation. Indeed, overexpression of SelT in PC12 cells provoked an increase in the concentration of intracellular Ca(2+) ([Ca(2+)](i)) that was dependent on the Sec residue. Conversely, SelT gene knockdown inhibited the PACAP-induced increase in [Ca(2+)](i) and reduced hormone secretion. These findings demonstrate the implication of a selenoprotein in the regulation of Ca(2+) homeostasis and neuroendocrine secretion in response to a cAMP-stimulating trophic factor.


Asunto(s)
Señalización del Calcio , Neurosecreción , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa/fisiología , Selenoproteínas/fisiología , Animales , Calcio/análisis , Diferenciación Celular , AMP Cíclico , Retículo Endoplásmico/química , Regulación de la Expresión Génica , Células PC12 , Ratas , Selenocisteína
13.
J Neurochem ; 107(2): 361-74, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18710417

RESUMEN

Urotensin II (UII) and UII-related peptide (URP) are paralog neuropeptides whose existence and distribution in mouse have not yet been investigated. In this study, we showed by HPLC/RIA analysis that the UII-immunoreactive molecule in the mouse brain corresponds to a new UII(17) isoform. Moreover, calcium mobilization assays indicated that UII(17) and URP were equally potent in stimulating UII receptor (UT receptor). Quantitative RT-PCR and in situ hybridization analysis revealed that in the CNS UII and URP mRNAs were predominantly expressed in brainstem and spinal motoneurons. Besides, they were differentially expressed in the medial vestibular nucleus, locus coeruleus and the ventral medulla. In periphery, both mRNAs were expressed in skeletal muscle, testis, vagina, stomach, and gall bladder, whereas only URP mRNA could be detected in the seminal vesicle, heart, colon, and thymus. By contrast, the UT receptor mRNA was widely expressed, and notably, very high amounts of transcript occurred in skeletal muscle and prostate. In the biceps femoris muscle, UII-like immunoreactivity was shown to coexist with synaptophysin in muscle motor end plate regions. Altogether these results suggest that (i) UII and URP may have many redundant biological effects, especially at the neuromuscular junction; (ii) URP may more specifically participate to autonomic, cardiovascular and reproductive functions.


Asunto(s)
Encéfalo/metabolismo , Unión Neuromuscular/metabolismo , Hormonas Peptídicas/metabolismo , ARN Mensajero/metabolismo , Receptores Acoplados a Proteínas G/genética , Urotensinas/metabolismo , Animales , Encéfalo/anatomía & histología , Células CHO , Calcio/metabolismo , Cromatografía Líquida de Alta Presión , Cricetinae , Cricetulus , Femenino , Masculino , Ratones , Radioinmunoensayo/métodos , Receptores Acoplados a Proteínas G/metabolismo , Sinaptofisina/metabolismo , Tirosina 3-Monooxigenasa/metabolismo , Urotensinas/química
14.
Neurosci Lett ; 414(3): 268-72, 2007 Mar 13.
Artículo en Inglés | MEDLINE | ID: mdl-17240057

RESUMEN

EM66 is a 66-amino acid peptide derived from secretogranin II, a member of granin acidic secretory protein family, by proteolytic processing. EM66 has been previously characterized in the jerboa (Jaculus orientalis) hypothalamus and its potential implication in the neuroendocrine regulation of feeding behaviour has been demonstrated. In the present study, an immunohistochemical analysis of the localization of EM66 within hypothalamic structures of rat was performed and compared to the distribution of EM66 in the jerboa hypothalamus. In the rat hypothalamus, as in the jerboa, EM66 immunostaining was detected in the parvocellular paraventricular, preoptic and arcuate nuclei, as well as the lateral hypothalamus which displayed an important density of EM66-producing neurones. However, unlike jerboa, the suprachiasmatic and supraoptic nuclei of the rat hypothalamus were devoid of cellular EM66-immunolabeling. Thus, the novel peptide EM66 may exert common neuroendocrine activities in rat and jerboa, e.g. control of food intake, and species-specific roles in jerboa such as the regulation of biological rhythms and hydromineral homeostasis. These results suggest the existence of differences between jerboas and rats in neuroendocrine regulatory mechanisms involving EM66.


Asunto(s)
Hipotálamo/metabolismo , Neuropéptidos/metabolismo , Fragmentos de Péptidos/metabolismo , Ratas Wistar/metabolismo , Roedores/metabolismo , Secretogranina II/metabolismo , Animales , Mapeo Encefálico , Conducta Alimentaria/fisiología , Femenino , Homeostasis/fisiología , Hipotálamo/anatomía & histología , Inmunohistoquímica , Masculino , Neuronas/metabolismo , Neuropéptidos/química , Sistemas Neurosecretores/metabolismo , Fragmentos de Péptidos/química , Periodicidad , Ratas , Ratas Wistar/anatomía & histología , Roedores/anatomía & histología , Secretogranina II/química , Especificidad de la Especie , Equilibrio Hidroelectrolítico/fisiología
15.
Sci Rep ; 7(1): 5172, 2017 07 12.
Artículo en Inglés | MEDLINE | ID: mdl-28701771

RESUMEN

Hormone secretion relies on secretory granules which store hormones in endocrine cells and release them upon cell stimulation. The molecular events leading to hormone sorting and secretory granule formation at the level of the TGN are still elusive. Our proteomic analysis of purified whole secretory granules or secretory granule membranes uncovered their association with the actomyosin components myosin 1b, actin and the actin nucleation complex Arp2/3. We found that myosin 1b controls the formation of secretory granules and the associated regulated secretion in both neuroendocrine cells and chromogranin A-expressing COS7 cells used as a simplified model of induced secretion. We show that F-actin is also involved in secretory granule biogenesis and that myosin 1b cooperates with Arp2/3 to recruit F-actin to the Golgi region where secretory granules bud. These results provide the first evidence that components of the actomyosin complex promote the biogenesis of secretory granules and thereby regulate hormone sorting and secretion.


Asunto(s)
Actinas/genética , Miosina Tipo I/genética , Vesículas Secretoras/metabolismo , Actinas/metabolismo , Animales , Transporte Biológico , Células COS , Proteínas Portadoras , Chlorocebus aethiops , Aparato de Golgi/metabolismo , Ratones , Miosina Tipo I/metabolismo , Células Neuroendocrinas/metabolismo , Sistemas Neurosecretores/metabolismo , Células PC12 , Unión Proteica , Ratas
16.
Ann N Y Acad Sci ; 1070: 431-5, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16888205

RESUMEN

We have previously shown that PACAP stimulates in vitro the secretion of corticosteroids by frog adrenal explants and that PACAP increases cAMP formation and cytosolic calcium concentration ('Ca2+'i) in adrenocortical cells. The aim of the present study was to investigate the involvement of cAMP and 'Ca2+'i in the stimulatory effect of PACAP on steroid production. Incubation of adrenal explants with PACAP resulted in a significant increase in total inositol phosphate formation. Administration of the protein kinase A inhibitor, H89, markedly reduced the stimulatory effect of PACAP on corticosterone and aldosterone secretion by perifused adrenal slices. In contrast, chelation of intracellular or extracellular calcium, or incubation with calcium channel blockers, had no effect on PACAP-evoked steroid secretion. Incubation of the cells with BAPTA or thapsigargin totally suppressed the stimulatory effect of PACAP on 'Ca2+'i. In contrast, suppression of extracellular calcium with EGTA or blockage of voltage-dependent Ca2+ channels did not impair PACAP-induced Ca2+ response. These data indicate that, in frog adrenocortical cells, the stimulatory effect of PACAP on steroid secretion is mediated through activation of the cAMP/PKA pathway. Concurrently, PACAP causes calcium mobilization from IP(3)-dependent intracellular stores through activation of a phospholipase C, while the calcium response is not involved in the stimulatory effect of PACAP on corticosteroid secretion.


Asunto(s)
Adenilil Ciclasas/metabolismo , Corteza Suprarrenal/efectos de los fármacos , Corteza Suprarrenal/metabolismo , Proteínas Quinasas Dependientes de AMP Cíclico/metabolismo , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa/farmacología , Rana esculenta/metabolismo , Transducción de Señal/efectos de los fármacos , Animales , Calcio/metabolismo , Bloqueadores de los Canales de Calcio/farmacología , Compuestos de Calcio/farmacología , Células Cultivadas , Cloratos/farmacología , Proteínas Quinasas Dependientes de AMP Cíclico/antagonistas & inhibidores , Fosfatos de Inositol/biosíntesis , Isoquinolinas/farmacología , Inhibidores de Proteínas Quinasas/farmacología , Esteroides/metabolismo , Sulfonamidas/farmacología
17.
Ann N Y Acad Sci ; 1070: 309-12, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16888183

RESUMEN

The aim of the present article was to examine the effect of PACAP on the release of the SgII-derived peptide EM66 from primary cultures of bovine chromaffin cells. PACAP dose dependently stimulated EM66 release from cultured chromaffin cells. A significant response was observed after 6 h of treatment with PACAP and increased to reach a 3.6-fold stimulation at 72 h. The stimulatory effect of PACAP was mediated through multiple signaling pathways, including calcium influx through L-type channels, PKA, PKC, and MAP-kinase cascades, to regulate EM66 release from chromaffin cells. These data suggest that EM66 may act downstream of the trans-synaptic stimulation of the adrenal medulla by neurocrine factors.


Asunto(s)
Células Cromafines/efectos de los fármacos , Células Cromafines/metabolismo , Cromograninas/metabolismo , Fragmentos de Péptidos/farmacología , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa/farmacología , Secretogranina II/farmacología , Animales , Bovinos , Células Cultivadas
18.
Ann N Y Acad Sci ; 1073: 527-32, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17102121

RESUMEN

The aim of the present study was to compare the expression levels of secretogranin II (SgII), prohormone convertases (PC)1 and PC2, and the proteolytic processing of SgII in benign versus malignant pheochromocytomas. Quantitative (Q)-PCR experiments indicated that SgII, PC1, and PC2 mRNAs were overexpressed in pheochromocytoma compared to non-tumoral chromaffin cells (P<0.001) and in benign compared to malignant tumors (P<0.01). Western blot analysis using a human SgII antiserum revealed the occurrence of a 97-kDa band corresponding to the expected size of SgII, with significantly higher quantities in benign than in malignant tumors (P<0.05). Using antisera directed against sequential regions of SgII (N-terminal, secretoneurin [SN], EM66, internal, and C-terminal sequences), we observed distinct processing profiles between benign and malignant pheochromocytomas. In contrast, using PC1 and PC2 antisera no differences between the two types of tumors were found. RIA measurement showed that EM66 median values between benign and malignant chromaffin cell tumors were significantly different (128.5 vs. 6.3 ng/mg protein, respectively; P<0.001). Taken together, these results indicate that, in pheochromocytoma, malignancy is associated with reduced PC1, PC2, and SgII mRNA expression and decreased levels of processing products of SgII, in line with the low concentrations of EM66 that occur in malignant tumors. These data support the notion that SgII-processing products, such as EM66, could represent prognostic markers of pheochromocytomas.


Asunto(s)
Neoplasias de las Glándulas Suprarrenales/diagnóstico , Perfilación de la Expresión Génica , Feocromocitoma/diagnóstico , Neoplasias de las Glándulas Suprarrenales/patología , Humanos , Análisis de Secuencia por Matrices de Oligonucleótidos , Feocromocitoma/patología , Pronóstico , Radioinmunoensayo
19.
Regul Pept ; 137(1-2): 79-88, 2006 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-16963134

RESUMEN

Secretoneurin (SN) and EM66 are two highly conserved peptides that derive from the processing of secretogranin II (SgII), one of the major constituents of chromaffin cell secretory vesicles. It has been shown that PACAP regulates SgII gene transcription and SN release in bovine adrenochromaffin cells. The aim of the present study was to localize and characterize EM66 in the bovine adrenal gland, and to examine the signaling pathways activated by PACAP to regulate the secretion of EM66 from cultured chromaffin cells. Double immunohistochemical labeling showed an intense EM66-immunoreactive (EM66-IR) signal in TH-positive medullary chromaffin cells of the adrenal gland. HPLC analysis combined with RIA detection revealed, in adrenal medulla extracts and cultured chromaffin cell media, the presence of a major EM66-IR peak co-eluting with the recombinant peptide. PACAP dose-dependently stimulated EM66 release from chromaffin cells (ED(50)=4.8 nM). The effect of PACAP on EM66 secretion was observed after 6 h of treatment and increased to reach a 2.6-fold stimulation at 48 h. The nonselective calcium channel blocker NiCl(2), the cytosolic calcium chelator BAPTA-AM and the L-type calcium channel blocker nimodipine significantly inhibited the stimulatory effect of PACAP on EM66 release. The secretory response to PACAP was also significantly lowered by the protein kinase A inhibitor H89 and by the protein kinase C inhibitor chelerythrine. Concomitant administration of chelerythrine, H89, NiCl(2) and BAPTA totally abolished PACAP-stimulated EM66 secretion. The MAPK inhibitors U0126 and SB203580 respectively decreased by 63% and 72% PACAP-evoked EM66 release. These results indicate that, in bovine adrenal medulla, SgII is processed to generate the EM66 peptide and that PACAP activates multiple signaling pathways to regulate EM66 release from chromaffin cells, suggesting that EM66 may act downstream of the trans-synaptic stimulation of the adrenal medulla by neurocrine factors.


Asunto(s)
Células Cromafines/fisiología , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa/fisiología , Transducción de Señal , Glándulas Suprarrenales/metabolismo , Animales , Western Blotting , Bovinos , Células Cromafines/metabolismo , Cromatografía Líquida de Alta Presión , Inmunohistoquímica , Técnicas In Vitro , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Fragmentos de Péptidos/metabolismo , Radioinmunoensayo , Secretogranina II/metabolismo
20.
J Clin Endocrinol Metab ; 88(6): 2579-85, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12788858

RESUMEN

EM66 is a novel secretogranin II-derived peptide present in chromaffin cells of the human adrenal gland. The aim of the present study was to investigate the possible occurrence of EM66 in benign and malignant pheochromocytomas. Immunohistochemical labeling using specific antibodies revealed intense staining in both benign and malignant tumors. Coincubation of pheochromocytoma slices with EM66 and tyrosine hydroxylase antibodies showed that the immunostaining was restricted to chromaffin cells. RIA experiments indicated that serial dilutions of extracts of benign and malignant tumors generated displacement curves that were parallel to those produced by recombinant EM66. RIA quantification revealed concentrations of EM66 immunoreactivity ranging from 3.2-210 ng/mg protein (median = 25.6 ng/mg protein) in benign pheochromocytomas, and from 2.9-6.3 ng/mg protein (median = 3.8 ng/mg protein) in malignant tumors. The EM66-like immunoreactivity contained in the pheochromocytoma extracts was characterized by HPLC analysis combined with RIA detection. All of the benign and malignant tumors examined exhibited a single immunoreactive peak coeluting with recombinant EM66. These data indicate that the secretogranin II-derived peptide EM66 is generated in human tumoral chromaffin tissue. The significant difference in EM66 concentrations observed between benign and malignant pheochromocytomas suggests that measurement of EM66 levels may help identifying patients with higher risk of progression of such tumors.


Asunto(s)
Neoplasias de las Glándulas Suprarrenales/metabolismo , Neoplasias de las Glándulas Suprarrenales/patología , Biomarcadores de Tumor/metabolismo , Fragmentos de Péptidos/metabolismo , Feocromocitoma/metabolismo , Feocromocitoma/patología , Proteínas/metabolismo , Secretogranina II/metabolismo , Adulto , Anciano , Western Blotting , Cromograninas , Diagnóstico Diferencial , Femenino , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Extractos de Tejidos/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA